(2005). Adiponectin and adiponectin receptors. Endocr Rev
(2006). Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. Obesity (Silver Spring)
(2005). Ahn JS: Antidiabetic effects of extracts from Psidium guajava.
(2003). AM: The prevalence and etiology of elevated aminotransferase levels in the United States.
(2010). Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extract. Nutr Metab
(1994). Arnason JT: Quercetin glycosides in Psidium guajava L. leaves and determination of a spasmolytic principle. Arch Med Res
(2009). Atherogenic dyslipidemia and altered hepatic gene expression in SHRSP.Z-Leprfa/IzmDmcr rats.
(2006). Bastard JP: Increased adiponectin receptor-1 expression in adipose tissue of impaired glucose-tolerant obese subjects during weight loss.
(2009). Bastard JP: The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol
(2006). BE: AMP-activated protein kinase-the fat controller of the energy railroad.
(1993). BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science
(2004). BS: Chemical constituents from the leaves of Psidium guajava. Nat Prod Res
(2005). C: Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors.
(2009). CM: Anthocyanins and tannins in ozonefumigated guava trees. Chemosphere
(2004). Establishment of a new animal model of metabolic syndrome: SHRSP fatty (fa/fa) rats. Clin Exp Pharmacol Physiol
(1957). GH: A simple method for the isolation and purification of total lipides from animal tissues.
(2005). Haffner SM: Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes
(2007). Hardie DG: AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res
(2000). Insights into insulin resistance and type 2 diabetes from knockout mouse models.
(2006). Kadowaki T: Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance.
(2007). Kadowaki T: Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med
(2001). Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med
(1998). Kadowaki T: Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
(2006). Mantzoros CS: Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training.
(2001). Melchionda N: Nonalcoholic fatty liver Yoshitomi et al.
(2008). NJ: Effect of guava (Psidium guajava Linn.) leaf soluble solids on glucose metabolism in type 2 diabetic rats. Phytother Res
(2001). Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr
(2001). Reddy JK: Peroxisomal beta-oxidation and steatohepatitis. Semin Liver Dis
(2006). Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Diabetologia
(2008). RV: Psidium guajava: a review of its traditional uses, phytochemistry and pharmacology.
(2004). T: Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity.
(2002). Two new triterpenoids from the fresh leaves of Psidium guajava. Planta Med
(1981). Understanding and treatment of diabetes mellitus by traditional Chinese medicine.
(2008). Yamori Y: Cardiovascular remodeling and metabolic abnormalities in SHRSP.Z-Lepr(fa)/IzmDmcr rats as a new model of metabolic syndrome. Hypertens Res
(1998). Yazawa K: Effects of dietary alpha-linolenic, eicosapentaenoic and docosahexaenoic acids on hepatic lipogenesis and beta-oxidation in rats. Biosci Biotechnol Biochem